Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 9Phase 1/2 7Phase NA 4Phase 3 1

Status

Withdrawn 4Recruiting 4Completed 4Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4Dermatologic 1

Conditions

Breast Neoplasms 1905Neoplasms 1528Prostatic Neoplasms 751Colorectal Neoplasms 714Lung Neoplasms 582Motor Activity 391Head and Neck Neoplasms 328Colonic Neoplasms 311Uterine Cervical Neoplasms 297Pain 247Pancreatic Neoplasms 246Anxiety Disorders 220Rectal Neoplasms 213Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 193Stomach Neoplasms 191Polycystic Ovary Syndrome 188Ovarian Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Brain Neoplasms 168Urinary Bladder Neoplasms 165Depression 164Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 137Lymphoma 135Lymphoma, Follicular 128Obesity 127

Interventions

apatinib 1Proton Therapy 1IPI-926 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Completed × Chondrosarcoma × Clear all
NCT01449149 2025-12-05

Proton Radiation for Chordomas and Chondrosarcomas

Abramson Cancer Center at Penn Medicine

Phase NA Completed
54 enrolled 11 charts
Sarcoma

Chondrosarcoma, Chordoma

NCT04260113 2021-01-05

AIAC

Peking University People's Hospital

Phase NA Completed
40 enrolled
Sarcoma

Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT03491371 2018-04-10

Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use

Peking University People's Hospital

Phase NA Completed
56 enrolled
Sarcoma

Chondrosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT01609179 2012-11-14

IPI-926 Extension Protocol for Continuation of Treatment With IPI-926

Infinity Pharmaceuticals, Inc.

Phase NA Completed
9 enrolled
DermatologicSarcoma

Carcinoma, Basal Cell, Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡